当前位置:首页 - 行情中心 - 华恒生物(688639) - 财务分析

华恒生物

(688639)

  

流通市值:186.15亿  总市值:186.56亿
流通股本:1.57亿   总股本:1.58亿

华恒生物(688639)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润0.86亿元,每股收益0.55元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益190176.88万元,未分配利润114142.96万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产438722.21万元,负债248545.33万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入500,781,373.591,938,268,117.781,364,161,262.06849,888,607.49
营业总成本411,603,470.891,447,706,028.021,006,806,422.12629,211,415.36
营业利润96,233,364.51510,903,260.37368,732,100.72226,664,202.42
利润总额96,585,933.92506,270,942.2362,680,736.7221,147,116.47
净利润85,868,603.65446,599,806.18319,399,135.43191,118,697.71
其他综合收益23,061.8281,725.54--
综合收益总额85,891,665.47446,681,531.72319,399,135.43191,118,697.71
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计1,208,314,144.171,050,046,406.02752,938,520.16758,682,145.42
非流动资产合计3,178,907,913.852,920,191,687.282,056,549,565.581,612,474,754.16
资产总计4,387,222,058.023,970,238,093.32,809,488,085.742,371,156,899.58
流动负债合计1,942,839,115.521,676,478,602.46794,776,651.78608,974,628.34
非流动负债合计542,614,164.39468,098,715.66313,329,539.55169,297,761.86
负债合计2,485,453,279.912,144,577,318.121,108,106,191.33778,272,390.2
归属于母公司股东权益合计1,903,784,686.211,826,971,175.811,700,780,695.111,591,851,196.19
股东权益合计1,901,768,778.111,825,660,775.181,701,381,894.411,592,884,509.38
负债和股东权益合计4,387,222,058.023,970,238,093.32,809,488,085.742,371,156,899.58
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计513,500,222.862,097,788,655.781,395,423,545.57888,055,905.92
经营活动现金流出小计616,915,968.411,796,371,440.431,025,434,972.19628,540,070.43
经营活动产生的现金流量净额-103,415,745.55301,417,215.35369,988,573.38259,515,835.49
投资活动现金流入小计2,748,300214,515,285.73225,872,421.56208,911,572.8
投资活动现金流出小计201,073,326.451,341,564,990.511,000,689,626.09525,733,533.37
投资活动产生的现金流量净额-198,325,026.45-1,127,049,704.78-774,817,204.53-316,821,960.57
筹资活动现金流入小计459,077,480.641,419,419,778.41650,026,302.53317,802,035.69
筹资活动现金流出小计142,473,770.11394,807,635.19217,041,290.17177,940,773.57
筹资活动产生的现金流量净额316,603,710.531,024,612,143.22432,985,012.36139,861,262.12
汇率变动对现金及现金等价物的影响3,069,171.516,540,841.695,988,825.934,050,616.83
现金及现金等价物净增加额17,932,110.04205,520,495.4834,145,207.1486,605,753.87
期末现金及现金等价物余额370,426,208.82352,494,098.78181,118,810.44233,579,357.17
最新报告期:2024-04-29
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
海通证券刘威3.955.397.272024-04-29
天风证券唐婕,张峰,邢颜凝4.205.326.542024-04-29
山西证券冀泳洁3.845.467.302024-04-25
国联证券柴沁虎3.905.507.002024-04-23
中信建投卢昊4.117.049.402024-04-23
TOP↑